Investing.com - Dr. Reddy’s Labs ADR reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Dr. Reddy’s Labs ADR announced earnings per share of 0.4639 on revenue of 653.93M. Analysts polled by Investing.com anticipated EPS of 0.5225 on revenue of 680.6M.
Dr. Reddy’s Labs ADR shares are down 23.04% from the beginning of the year and are trading at 51.49 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Dr. Reddy’s Labs ADR follows other major Healthcare sector earnings this month
Dr. Reddy’s Labs ADR's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of 5.57 on revenue of 80.33B, compared to forecasts EPS of 5.21 on revenue of 79.68B.
J&J had beat expectations on July 19 with second quarter EPS of 2.59 on revenue of 24.02B, compared to forecast for EPS of 2.54 on revenue of 23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar